Trial · NCT02021292
Results by group46
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 46
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline to Week 16 in Pulmonary Vascular Resistance (PVR) at Rest. | Macitentan | 73.0 | 95% Confidence Interval 63.6 to 83.8 | percent of baseline PVR | |
| Change From Baseline to Week 16 in Pulmonary Vascular Resistance (PVR) at Rest. | Placebo | 87.2 | 95% Confidence Interval 78.5 to 96.7 | percent of baseline PVR | |
| Change From Baseline to Week 24 in Exercise Capacity, as Measured by the 6-minute Walk Distance (6MWD). | Macitentan | 6MWD (m) at baseline | 353.0 | Standard Deviation 87.90 | meter |
| Change From Baseline to Week 24 in Exercise Capacity, as Measured by the 6-minute Walk Distance (6MWD). | Placebo | 6MWD (m) at baseline | 351.2 | Standard Deviation 73.79 | meter |
| Change From Baseline to Week 24 in Exercise Capacity, as Measured by the 6-minute Walk Distance (6MWD). | Macitentan | 6MWD (m) at Week 24 | 388.0 | Standard Deviation 83.31 | meter |
| Change From Baseline to Week 24 in Exercise Capacity, as Measured by the 6-minute Walk Distance (6MWD). | Placebo | 6MWD (m) at Week 24 | 352.2 | Standard Deviation 121.29 | meter |
| Change From Baseline to Week 24 in Exercise Capacity, as Measured by the 6-minute Walk Distance (6MWD). | Macitentan | Change in 6MWD (m) from baseline to Week 24 | 35.0 | Standard Deviation 52.52 | meter |
| Change From Baseline to Week 24 in Exercise Capacity, as Measured by the 6-minute Walk Distance (6MWD). | Placebo | Change in 6MWD (m) from baseline to Week 24 | 1.0 | Standard Deviation 83.24 | meter |
| Change From Baseline to Week 24 in Borg Dyspnea Index Collected at the End of the 6-minute Walk Test (6MWT). | Macitentan | Borg dyspnea index score at baseline | 4.2 | Standard Deviation 2.52 | Score on a scale |
| Change From Baseline to Week 24 in Borg Dyspnea Index Collected at the End of the 6-minute Walk Test (6MWT). | Placebo | Borg dyspnea index score at baseline | 4.2 | Standard Deviation 2.14 | Score on a scale |
| Change From Baseline to Week 24 in Borg Dyspnea Index Collected at the End of the 6-minute Walk Test (6MWT). | Macitentan | Borg dyspnea index score at Week 24 | 4.1 | Standard Deviation 2.52 | Score on a scale |
| Change From Baseline to Week 24 in Borg Dyspnea Index Collected at the End of the 6-minute Walk Test (6MWT). | Placebo | Borg dyspnea index score at Week 24 | 4.4 | Standard Deviation 2.45 | Score on a scale |
| Change From Baseline to Week 24 in Borg Dyspnea Index Collected at the End of the 6-minute Walk Test (6MWT). | Macitentan | Change from baseline to Week 24 | -0.1 | Standard Deviation 1.86 | Score on a scale |
| Change From Baseline to Week 24 in Borg Dyspnea Index Collected at the End of the 6-minute Walk Test (6MWT). | Placebo | Change from baseline to Week 24 | 0.3 | Standard Deviation 2.04 | Score on a scale |
| Proportion of Subjects With Worsening in WHO Functional Class (FC) From Baseline to Week 24 | Macitentan | WHO functional class I at baseline | 0 | Participants | |
| Proportion of Subjects With Worsening in WHO Functional Class (FC) From Baseline to Week 24 | Placebo | WHO functional class I at baseline | 0 | Participants | |
| Proportion of Subjects With Worsening in WHO Functional Class (FC) From Baseline to Week 24 | Macitentan | WHO functional class II at baseline | 12 | Participants | |
| Proportion of Subjects With Worsening in WHO Functional Class (FC) From Baseline to Week 24 | Placebo | WHO functional class II at baseline | 6 | Participants | |
| Proportion of Subjects With Worsening in WHO Functional Class (FC) From Baseline to Week 24 | Macitentan | WHO functional class III at baseline | 28 | Participants | |
| Proportion of Subjects With Worsening in WHO Functional Class (FC) From Baseline to Week 24 | Placebo | WHO functional class III at baseline | 33 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02021292/results